George Matcham Buys Shares of TIL $TIL
Key Points
- George Matcham bought 6,500 shares of Instil Bio, Inc. ($TIL).
- $TIL last traded around $7.92.
George Matcham, insider at Instil Bio, Inc. ($TIL), bought 6,500 shares at an average price of $0.00. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
Instil Bio, Inc. ($TIL) Stock
Last price$7.92
Market cap$53.71M
Forward P/E-0.54
Beta1.91
52-week low$5.67
52-week high$35.00
50-day MA$8.17
200-day MA$12.09
Current ratio39.87
Quick ratio15.79
Debt-to-equity0.77
Instil Bio, Inc. Earnings
EPS (ttm)$-7.00
Revenue (ttm)—
Net margin0.0%
Return on equity-37.1%
Next earningsMar 4, 2026
Analysts Set New Price Targets
Average target$7.00
High target$7.00
Low target$7.00
Analysts covering1
About Instil Bio, Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
ExchangeNasdaqCM
SectorHealthcare
IndustryBiotechnology
HeadquartersDallas, TX
CEOMr. Bronson Crouch
Employees17
Websitehttps://instilbio.com
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.